Real-World Efficacy and Hematologic Toxicity of Azacitidine and Venetoclax in a Cohort of Elderly Patients Unfit for Intensive Chemotherapy With Newly Diagnosed Acute Myeloid Leukemia

被引：0
|
作者：
Wysoglad, Hubert [1 ,2 ]
Krawczyk, Katarzyna [2 ,3 ]
Ochrem, Bogdan [2 ,3 ]
Madry, Krzysztof [1 ]
Drozd-Sokolowska, Joanna [1 ]
Sacha, Tomasz [2 ,3 ]
Basak, Grzegorz [1 ]
机构：
[1] Med Univ Warsaw, Dept Hematol Transplantol & Internal Med, Warsaw, Poland
[2] Univ Hosp Krakow, Dept Hematol, Krakow, Poland
[3] Jagiellonian Univ Med Coll, Dept Hematol, Krakow, Poland
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
acute myeloid leukemia; azacitidine; venetoclax; real-world evidence;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-384
引用
收藏
页码：S294 / S294
页数：1
相关论文
共 50 条
  • [41] Fix low dose venetoclax-azacitidine treatment of unfit acute myeloid leukemia patients
    Miklos, Egyed
    Oliver, Toth Peter
    Adam, Kellner
    Eva, Karadi
    Balazs, Kollar
    Eszter, Kovacs
    Anett, Pavlovics
    Viktoria, Gyori-Korom
    Jozsef, Herczeg
    Peter, Rajnics
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (02) : 183 - 189
  • [42] Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience
    Chen, Yi
    Cao, Jing
    Ye, Yaozhen
    Luo, Luting
    Zheng, Xiaoyun
    Yang, Xiaozhu
    Zheng, Zhihong
    Zheng, Jing
    Yang, Ting
    Hu, Jianda
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (04) : 322 - 329
  • [43] Revisiting the Real-World Prognosis of Intensive Chemotherapy in Elderly Acute Myeloid Leukemia Patients: A Retrospective Analysis from Tokyo
    Hagino, Takeshi
    Saga, Reina
    Hidai, Hiroko
    Tsutsumi, Hisashi
    Akiyama, Hideki
    Murai, Yoshiro
    Mori, Mayumi
    Motomura, Sayuri
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024,
  • [44] Outpatient Low-Dose Venetoclax Plus Azacitidine Vs. Intensive Chemotherapy for Newly Diagnosed Fit Patients with Acute Myeloid Leukemia in a Limited Resource Setting
    Lopez-Garcia, Yadith Karina
    De La Garza, Fernando
    De la Rosa-Flores, Gerardo Alexis
    Coronado Alejandro, Edgar Ulises
    Vega-Mateos, Antonio
    Tejada Vasquez, Ana Cristina
    Garcia-Salas, Gerardo
    Garcia-Zarate, Valeria
    Colunga-Pedraza, Perla R. Rocio
    Gomez-Almaguer, David
    Gomez-De Leon, Andres
    BLOOD, 2023, 142
  • [45] Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia
    Matthews, Andrew H.
    Perl, Alexander E.
    Luger, Selina M.
    Gill, Saar I.
    Lai, Catherine
    Porter, David L.
    Skuli, Sarah
    Bruno, Ximena Jordan
    Carroll, Martin P.
    Freyer, Craig W.
    Carulli, Alison
    Babushok, Daria V.
    Frey, Noelle V.
    Hexner, Elizabeth O.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Stadtmauer, Edward A.
    Loren, Alison W.
    Paralkar, Vikram R.
    Maillard, Ivan P.
    Pratz, Keith W.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : 1254 - 1264
  • [46] Cost Effectiveness Analysis of Venetoclax Plus Azacitidine Versus Azacitidine in Newly Diagnosed Adult Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy from a United States Payer Perspective
    Pratz, Keith W.
    Chai, Xinglei
    Xie, Jipan
    Yin, Lei
    Nie, Xiaoyu
    Montez, Melissa
    Iantuono, Erica
    Downs, Lisa
    Ma, Esprit
    BLOOD, 2021, 138
  • [47] Selinexor in Combination with Venetoclax and Azacitidine for Newly Diagnosed (ND) Unfit Acute Myeloid Leukemia (AML): A Multicenter, Open-Label Prospective Study
    Yang, Li
    Chen, Fangli
    Liang, Hong
    Bai, Yunsong
    Wu, Wenzhong
    Yan, Xiaojing
    Ren, Jinhai
    Li, Si
    Yu, Yang
    Tong, Laigen
    Pan, Deng
    Liu, Ligen
    BLOOD, 2023, 142
  • [48] Hematologic improvements with ivosidenib plus azacitidine compared to placebo plus azacitidine in patients with newly diagnosed acute myeloid leukemia.
    Dohner, Hartmut
    Montesinos, Pau
    Polo, Susana Vives
    Zarzycka, Ewa
    Wang, Jianxiang
    Bertani, Giambattista
    Heuser, Michael
    Calado, Rodrigo T.
    Schuh, Andre C.
    Yeh, Su-Peng
    Burguera, Adolfo de la Fuente
    Cerchione, Claudio
    Daigle, Scott
    Hui, Jianan
    Pandya, Shuchi Sumant
    Gianolio, Diego A.
    Recher, Christian
    De Botton, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Efficacy and Safety of Low-Dose Venetoclax Combined with Voriconazole Inpatients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy
    Meng, Danchen
    Ruan, Min
    Liu, Xinyao
    Wu, Wei
    Zhuang, Junling
    Ge, Jian
    Huang, Zhenqi
    Long, Zhangbiao
    BLOOD, 2023, 142
  • [50] Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry
    Labrador, Jorge
    Martinez-Cuadron, David
    de la Fuente, Adolfo
    Rodriguez-Veiga, Rebeca
    Serrano, Josefina
    Tormo, Mar
    Perez-Simon, Jose Antonio
    Ramos, Fernando
    del Castillo, Teresa Bernal
    Lopez-Pavia, Maria
    Trigo, Fernanda
    Sanchez, Pilar Martinez
    Rodriguez-Gutierrez, Juan Ignacio
    Rodriguez, Carlos
    Gil, Cristina
    Garcia, Daniel
    Vives, Susana
    Foncillas, Maria Angeles
    Encinas, Manuel Perez
    Novo, Andres
    Recio, Isabel
    Rodriguez-Macias, Gabriela
    Burgues, Juan Miguel Bergua
    Concepcion, Victor Noriega
    Lavilla, Esperanza
    Perez, Alicia Roldan
    Sanz, Miguel A.
    Montesinos, Pau
    BLOOD, 2020, 136
12345